𝔖 Bobbio Scriptorium
✦   LIBER   ✦

RGS16Is a Marker for Prognosis in Colorectal Cancer

✍ Scribed by Norikatsu Miyoshi; Hideshi Ishii; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori

Book ID
111773234
Publisher
Springer
Year
2009
Tongue
English
Weight
375 KB
Volume
16
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

SCRN1 is a novel marker for prognosis in
SCRN1 is a novel marker for prognosis in colorectal cancer
✍ Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Mitsugu Sekimoto; Yuichiro Doki; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

## Abstract ## Purpose Secernin 1 (__SCRN1__) is a member of the secernin family and is reported to be a tumor‐associated antigen. Previous reports show that __SCRN1__ is upregulated in gastric cancer cell lines and may be a novel immunotherapy target, whereas its significance in colorectal cancer

SMAD7 is a prognostic marker in patients
SMAD7 is a prognostic marker in patients with colorectal cancer
✍ Jean-Louis Boulay; Gabriele Mild; Adam Lowy; Juergen Reuter; Magali Lagrange; Lu πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 82 KB

## Abstract Chromosomal region 18q21 is frequently deleted in colorectal cancer (CRC) and is associated with poor prognosis. Potential tumor suppressor mechanisms altered by 18q21 deletion include mediation of TGFΞ² signaling by SMADs. Following the definition of __SMAD4__ deletion as a negative pre